These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 30984181

  • 1. Neoadjuvant Radiochemotherapy Significantly Alters the Phenotype of Plasmacytoid Dendritic Cells and 6-Sulfo LacNAc+ Monocytes in Rectal Cancer.
    Wagner F, Hölig U, Wilczkowski F, Plesca I, Sommer U, Wehner R, Kießler M, Jarosch A, Flecke K, Arsova M, Tunger A, Bogner A, Reißfelder C, Weitz J, Schäkel K, Troost EGC, Krause M, Folprecht G, Bornhäuser M, Bachmann MP, Aust D, Baretton G, Schmitz M.
    Front Immunol; 2019; 10():602. PubMed ID: 30984181
    [Abstract] [Full Text] [Related]

  • 2. Current Concepts on 6-sulfo LacNAc Expressing Monocytes (slanMo).
    Ahmad F, Döbel T, Schmitz M, Schäkel K.
    Front Immunol; 2019; 10():948. PubMed ID: 31191513
    [Abstract] [Full Text] [Related]

  • 3. Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer.
    Kießler M, Plesca I, Sommer U, Wehner R, Wilczkowski F, Müller L, Tunger A, Lai X, Rentsch A, Peuker K, Zeissig S, Seifert AM, Seifert L, Weitz J, Bachmann M, Bornhäuser M, Aust D, Baretton G, Schmitz M.
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33762320
    [Abstract] [Full Text] [Related]

  • 4. Accumulation of tolerogenic human 6-sulfo LacNAc dendritic cells in renal cell carcinoma is associated with poor prognosis.
    Toma M, Wehner R, Kloß A, Hübner L, Fodelianaki G, Erdmann K, Füssel S, Zastrow S, Meinhardt M, Seliger B, Brech D, Noessner E, Tonn T, Schäkel K, Bornhäuser M, Bachmann MP, Wirth MP, Baretton G, Schmitz M.
    Oncoimmunology; 2015 Jun; 4(6):e1008342. PubMed ID: 26155414
    [Abstract] [Full Text] [Related]

  • 5. Phenotype, Function, and Mobilization of 6-Sulfo LacNAc-Expressing Monocytes in Atopic Dermatitis.
    Baran W, Oehrl S, Ahmad F, Döbel T, Alt C, Buske-Kirschbaum A, Schmitz M, Schäkel K.
    Front Immunol; 2018 Jun; 9():1352. PubMed ID: 29977237
    [Abstract] [Full Text] [Related]

  • 6. 6-Sulfo LacNAc monocytes are quantitatively and functionally disturbed in systemic sclerosis patients.
    Ricard L, Eshagh D, Siblany L, de Vassoigne F, Malard F, Laurent C, Beurier P, Jachiet V, Rivière S, Fain O, Mohty M, Gaugler B, Mekinian A.
    Clin Exp Immunol; 2022 Aug 19; 209(2):175-181. PubMed ID: 35758259
    [Abstract] [Full Text] [Related]

  • 7. Intracapillary immune complexes recruit and activate slan-expressing CD16+ monocytes in human lupus nephritis.
    Olaru F, Döbel T, Lonsdorf AS, Oehrl S, Maas M, Enk AH, Schmitz M, Gröne EF, Gröne HJ, Schäkel K.
    JCI Insight; 2018 Jun 07; 3(11):. PubMed ID: 29875315
    [Abstract] [Full Text] [Related]

  • 8. Infliximab induces downregulation of the IL-12/IL-23 axis in 6-sulfo-LacNac (slan)+ dendritic cells and macrophages.
    Brunner PM, Koszik F, Reininger B, Kalb ML, Bauer W, Stingl G.
    J Allergy Clin Immunol; 2013 Nov 07; 132(5):1184-1193.e8. PubMed ID: 23890755
    [Abstract] [Full Text] [Related]

  • 9. Increased tumor-infiltrating plasmacytoid dendritic cells predicts poor prognosis in oral squamous cell carcinoma.
    Han N, Zhang Z, Liu S, Ow A, Ruan M, Yang W, Zhang C.
    Arch Oral Biol; 2017 Jun 07; 78():129-134. PubMed ID: 28242507
    [Abstract] [Full Text] [Related]

  • 10. Dysfunctional DC subsets in RCC patients: ex vivo correction to yield an effective anti-cancer vaccine.
    Gigante M, Blasi A, Loverre A, Mancini V, Battaglia M, Selvaggi FP, Maiorano E, Napoli A, Castellano G, Storkus WJ, Gesualdo L, Ranieri E.
    Mol Immunol; 2009 Feb 07; 46(5):893-901. PubMed ID: 19041139
    [Abstract] [Full Text] [Related]

  • 11. Oncological short-term effects and adverse events of MRI-guided selective neoadjuvant radiochemotherapy for rectal cancer.
    Maurer CA, Mattiello D, Duwe J, Ruppert R, Ptok H, Strassburg J, Junginger T, Merkel S, Hermanek P.
    Anticancer Res; 2012 May 07; 32(5):1721-8. PubMed ID: 22593452
    [Abstract] [Full Text] [Related]

  • 12. Significance of tumor-infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer.
    Matsutani S, Shibutani M, Maeda K, Nagahara H, Fukuoka T, Nakao S, Hirakawa K, Ohira M.
    Cancer Sci; 2018 Apr 07; 109(4):966-979. PubMed ID: 29464828
    [Abstract] [Full Text] [Related]

  • 13. Human 6-sulfo LacNAc (slan) dendritic cells have molecular and functional features of an important pro-inflammatory cell type in lupus erythematosus.
    Hänsel A, Günther C, Baran W, Bidier M, Lorenz HM, Schmitz M, Bachmann M, Döbel T, Enk AH, Schäkel K.
    J Autoimmun; 2013 Feb 07; 40():1-8. PubMed ID: 22890025
    [Abstract] [Full Text] [Related]

  • 14. Human innate immune cell crosstalk induces melanoma cell senescence.
    Funck F, Pahl J, Kyjacova L, Freund L, Oehrl S, Gräbe G, Pezer S, Hassel JC, Sleeman J, Cerwenka A, Schäkel K.
    Oncoimmunology; 2020 Aug 30; 9(1):1808424. PubMed ID: 32939325
    [Abstract] [Full Text] [Related]

  • 15. [Changes in the CD8+ Density of Tumor Infiltrating Lymphocytes after Neoadjuvant Radiochemotherapy in Patients with Rectal Adenocarcinom].
    Buka D, Dvořák J, Sitorová V, Hátlová J, Richter I, Sirák I.
    Klin Onkol; 2016 Aug 30; 29(3):204-9. PubMed ID: 27296405
    [Abstract] [Full Text] [Related]

  • 16. Magnetic resonance imaging radiomics-based prediction of severe inflammatory response in locally advanced rectal cancer patients after neoadjuvant radiochemotherapy.
    Chen L, Zhu W, Zhang W, Chen E, Zhou W.
    Langenbecks Arch Surg; 2024 Jul 17; 409(1):218. PubMed ID: 39017754
    [Abstract] [Full Text] [Related]

  • 17. Impact of chemotherapeutic agents on the immunostimulatory properties of human 6-sulfo LacNAc+ (slan) dendritic cells.
    Wehner R, Bitterlich A, Meyer N, Kloß A, Schäkel K, Bachmann M, Schmitz M.
    Int J Cancer; 2013 Mar 15; 132(6):1351-9. PubMed ID: 22907335
    [Abstract] [Full Text] [Related]

  • 18. Human Plasmacytoid and Monocyte-Derived Dendritic Cells Display Distinct Metabolic Profile Upon RIG-I Activation.
    Fekete T, Sütö MI, Bencze D, Mázló A, Szabo A, Biro T, Bacsi A, Pazmandi K.
    Front Immunol; 2018 Mar 15; 9():3070. PubMed ID: 30622542
    [Abstract] [Full Text] [Related]

  • 19. Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor: implications for live kidney cancer vaccines.
    Mulders P, Tso CL, Gitlitz B, Kaboo R, Hinkel A, Frand S, Kiertscher S, Roth MD, deKernion J, Figlin R, Belldegrun A.
    Clin Cancer Res; 1999 Feb 15; 5(2):445-54. PubMed ID: 10037196
    [Abstract] [Full Text] [Related]

  • 20. CD8+ and FOXP3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer.
    Shinto E, Hase K, Hashiguchi Y, Sekizawa A, Ueno H, Shikina A, Kajiwara Y, Kobayashi H, Ishiguro M, Yamamoto J.
    Ann Surg Oncol; 2014 Jun 15; 21 Suppl 3():S414-21. PubMed ID: 24566864
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.